Skip to main content
Clinical Trials/CTRI/2022/03/041123
CTRI/2022/03/041123
Completed
Phase 3

An exploratory clinical study to evaluate the efficacy of Samangadi Taila Pichu-dharana and Dashmooladi Taila Matra Basti in the management of Prasramsini Yonivyapad (uterine prolapse)

All India Institute of Ayurveda New Delhi0 sites30 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: N819- Female genital prolapse, unspecified
Sponsor
All India Institute of Ayurveda New Delhi
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 30, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
All India Institute of Ayurveda New Delhi

Eligibility Criteria

Inclusion Criteria

  • 1\. Female patients of Age group: 25\-65 years
  • 2\.1st and 2nd degree uterine prolapse with or without cystocele or rectocele.

Exclusion Criteria

  • 1\. 3rd degree prolapse and procidentia
  • 2\. Active infection in vagina
  • 3\. Pregnant women
  • 4\. Congenital anomalies
  • 6\. Infectious, benign or malignant growth of genital organs
  • Carcinoma of cervix

Outcomes

Primary Outcomes

Not specified

Similar Trials